Clinical Trial Update: Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/2 clinical trial evaluating magnetic resonance spectroscopic imaging and tumor perfusion in glioblastoma patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Glioblastoma, Glioma | Phase 1, Phase 2 | Status: COMPLETED